Arkolith/Insider Trading/OCX/Form 4

Arno Andrew

DirectorOncocyte Corp (OCX) · full profile →Form 4 · filed Apr 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 3, 2023Grant(A)141K$0.35$49K673K
Apr 3, 2023Grant(A)141K$0.35$49K156K
Apr 3, 2023Grant(A)141K$0.35$49K156K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-011104) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML